Grifols S.A. (GIFLF)
PNK: GIFLF
· Real-Time Price · USD
8.50
0.00 (0.00%)
At close: Apr 30, 2025, 8:00 PM
0.00% (1D)
| Bid | 8.5 |
| Market Cap | 5.22B |
| Revenue (ttm) | 7.21B |
| Net Income (ttm) | 156.92M |
| EPS (ttm) | 0.26 |
| PE Ratio (ttm) | 32.69 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 9.92 |
| Volume | 2,200 |
| Avg. Volume (20D) | 65 |
| Open | 9.52 |
| Previous Close | 8.50 |
| Day's Range | 8.50 - 9.53 |
| 52-Week Range | 8.40 - 11.39 |
| Beta | 0.92 |
About GIFLF
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solutions to treat patients with chronic, rare, prevalent, and life-threatening diseases. It offers immunogl...
Industry Drug Manufacturers - General
Sector Healthcare
IPO Date Jun 24, 2008
Employees 23,833
Stock Exchange PNK
Ticker Symbol GIFLF
Website https://www.grifols.com